Perfil clínico-epidemiológico del paciente con insuficiencia cardiaca en un hospital universitario

  1. Mª Candelaria Fraga González
  2. Lucía Cid Conde
  3. Teresa Alves Pérez
  4. Cristina Martín Godínez
  5. Pilar Alonso Álvarez
  6. José López Castro
Revista:
Metas de enfermería

ISSN: 1138-7262

Ano de publicación: 2019

Volume: 22

Número: 4

Páxinas: 65-70

Tipo: Artigo

DOI: 10.35667/METASENF.2019.22.1003081408 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Metas de enfermería

Obxectivos de Desenvolvemento Sustentable

Resumo

Objective: to understand the sociodemographical and clinical profile of the patient with heart failure managed at a University Hospital. Method: a prospective observational study in a cohort of patients managed for heart failure between January 1st, 2003 and December 31st, 2006 at the Complexo Hospitalario Universitario of Orense. Clinical-epidemiological data were collected through the review of clinical records. Descriptive and analytical analysis; statistical program SPSS version 22.0. Results: the sample included 665 patients, with a mean age (standard deviation) of 76.51 (10.37) years; 54.4% of them were male, and 69.3% lived in the rural area. Of these patients, 56.7% were admitted at the Cardiology Unit; 55.6% (n= 370) of them had their left ventricular ejection fraction (LVEF) preserved. Also, 52.8% of the patients presented hypertension (HTN) as clinical background, and 68.0% presented dyspnea at admission. The most widely prescribed treatments at discharge where non-K+-saving diuretics (85.4%), ACE inhibitors-ARBs (66%) and antiaggregants (42.10%). Conclusions: the most typical profile of patients managed for heart failure at the centre is a male >65-year-old patient, living in the rural setting, with preserved LVEF, where the most prevalent clinical background is HTN, and with dyspnea as the most usual symptom; this patient requires pharmacological treatment with non-K+-saving diuretics, ACE inhibitors-ARBs and antiaggregants for disease control.

Referencias bibliográficas

  • Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013; 127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad.
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Euro Heart J. 2016; 37(27):2129200. Doi:10.1093/eurheartj/ehw128.
  • O´Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 2003; 13(4):S107-12.
  • Ess SM, Luscher TF, Szucs TD. High dose lisinopril in heart failure: economic considerations. Cardiovasc Drugs Ther 2002; 16(4):365-71.
  • Delgado Pascual-Figal D, Grillo JJ, Comín-Colet J, Díaz B, Martínez de la Concha L, Martí B, et al. Costes sanitarios y no sanitarios de personas que padecen insuficiencia cardiaca crónica sintomática en España. Rev. Esp. Cardiol. 2014; 67(8):643-50.
  • Moster A, Cost B, Hoes AW, De Bruijene MC, Deckers JW, Hofman A, et al. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J. 2001; 22(15):1318-27.
  • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Euro Heart J. 2012; 33:1787-847.
  • Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28:1-39.
  • Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM, et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr. 2008; 21(11):1179-201.
  • García Castelo A, Muñiz García J, Sesma Sánchez P, Castro Beiras A. Utilización de recursos diagnósticos y terapéuticos en pacientes ingresados por insuficiencia cardiaca: influencia del servicio de ingreso (estudio INCARGAL). Rev Esp Cardiol. 2003; 56:49-56.
  • Montes J, Chouciño T, Gómez- Guiguirey A, Pesqueira P, Cerqueiro J, Castro J, et al. Características epidemiológicas de los pacientes ingresados por insuficiencia cardiaca en medicina interna en Galicia: estudio SOGAMI-IC. Rev. Clin Esp. 2010 (S); 210: 241.
  • Otero- Raviña F, Grigorian- Shamagian L, Fransi-Galiana L. Estudio gallego de insuficiencia cardiaca en Atención Primaria (estudio GALIPAP). Rev Esp Cardiol. 2007; 60:373-83.
  • López Castro J, Almazán Ortega R, Pérez de Juan Romero M, González Juanatey JR. Factores pronósticos de mortalidad de la insuficiencia cardiaca en una cohorte del noroeste de España. Estudio EPICOUR. Rev Clin Esp. 2010; 210:438-47.
  • Filippatos G, Khan SS, Ambrosy AP, Cleland JGF, Collins SP, Lam CSP, et al. International Registry to assess medical Practice with longitudinal Observation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. Eur J Heart Fail 2015; 17:527-33.
  • Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2014; 27:911-39.
  • Louie HW, Laks H, Milgalter E. Ischemic cardiomiophaty: criteria for coronary revascularization and cardiac transplantation. Circulation 1991; 84: III290-III295.
  • Rankin SH, Stallings KD. Patient education, principales and practice. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001.
  • Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos (59ª Asamblea General, Seúl, Corea, octubre 2008) Punto 32.
  • Boletín Oficial del Estado (BOE), núm. 251, de 20 de octubre de 1999, páginas 36825 a 36830. [internet]. [citado 8 abr 2019]. Disponible en: http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobkey=id&blobtable=MungoBlobs&blobwhere=1352818183776&ssbinary=true
  • Boletín Oficial del Estado (BOE), núm. 93, de 19 de abril de 2005, páginas 13364 a 13368. [internet]. [citado 8 abr 2019]. Disponible en: https://www.boe.es/boe/dias/2005/04/19/pdfs/A13364-13368.pdf.
  • Permanyer Miralda G, Soriano N, Brotons C, Moral I, Pinar J, Cascant P, Ribera A, et al. Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardiaca en un hospital general. Rev. Esp Cardiol. 2002; 55:571-8.
  • Montes-Santiago J, Rey García G, Mediero Domínguez A. Economic burden of heart failure in Galicia (Northwest of Spain): The GALICEP- costes study. European Federation of Internal Medicine, 6th Congress. Lisbon 2007 (May 23-26), Abstract book: P- 49-07.
  • Anguita Sánchez M e investigadores del Registro BADAPIC. Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con IC controlados en consultas específicas de IC. Resultados de lRegistro BADAPIC. Rev Esp Cardiol. 2004; 57:1159-69.
  • Anguita Sánchez M, Crespo Leiro MG, de Teresa Galván E, Jiménez Navarro M, Alonso-Pulpón L, Muñiz García J; PRICE Study Investigators. Prevalence of Heart Failure in the Spanish General Population aged over 45 years. The PRICE Study. Rev Esp Cardiol. 2008; 61(10):1041-9.
  • Antonelli Incalzi R, Pedone C, Pahor M, Onder G, Carbonin PU. Grupo italiano de farmacovigilancia del anciano. Trends in prescribing ACE-inhibitors for congestive heart failure in elderly people. Aging ClinExp Res 2002; 14(6):516-21.
  • Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007; 153(6):1021-8.
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18:891-975.
  • Montes Santiago J. Epidemiología de la insuficiencia cardiaca: aproximación del paciente real en Galicia. Galicia Clin 2012; 73(Supl 2):S5-S11.
  • McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med.1971; 285(26):1441-6.
Fonte de datos: Dialnet